These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A peripherally acting, selective T-type calcium channel blocker, ABT-639, effectively reduces nociceptive and neuropathic pain in rats. Jarvis MF; Scott VE; McGaraughty S; Chu KL; Xu J; Niforatos W; Milicic I; Joshi S; Zhang Q; Xia Z Biochem Pharmacol; 2014 Jun; 89(4):536-44. PubMed ID: 24726441 [TBL] [Abstract][Full Text] [Related]
7. The role of T-type calcium channels in epilepsy and pain. Nelson MT; Todorovic SM; Perez-Reyes E Curr Pharm Des; 2006; 12(18):2189-97. PubMed ID: 16787249 [TBL] [Abstract][Full Text] [Related]
8. Evolutionary insights into T-type Ca Smith CL; Abdallah S; Wong YY; Le P; Harracksingh AN; Artinian L; Tamvacakis AN; Rehder V; Reese TS; Senatore A J Gen Physiol; 2017 Apr; 149(4):483-510. PubMed ID: 28330839 [TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice. Kraus RL; Li Y; Gregan Y; Gotter AL; Uebele VN; Fox SV; Doran SM; Barrow JC; Yang ZQ; Reger TS; Koblan KS; Renger JJ J Pharmacol Exp Ther; 2010 Nov; 335(2):409-17. PubMed ID: 20682849 [TBL] [Abstract][Full Text] [Related]
10. Biophysics and structure-function relationship of T-type Ca2+ channels. Talavera K; Nilius B Cell Calcium; 2006 Aug; 40(2):97-114. PubMed ID: 16777221 [TBL] [Abstract][Full Text] [Related]